A phase I trial of intracranial dendritic cell immunotherapy for patients with malignant glioma

被引：0
|
作者：
Yu, John S.
Liu, Gentao
Ng, Hiushan
Wagenberg, Mia
Luptrawan, Anne
Mindlin, Elina
Wheeler, Christopher J.
Black, Keith L.
机构：
来源：
NEUROSURGERY | 2006年 / 59卷 / 02期
关键词：
D O I：
10.1227/00006123-200608000-00132
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [21] Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Sano, M
    Kobayashi, T
    Yoshida, S
    Abe, T
    Narita, M
    Takahashi, M
    Tanaka, R
    CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4160 - 4167
  • [22] Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma
    Sakai, Keiichi
    Shimodaira, Shigetaka
    Maejima, Shinya
    Udagawa, Nobuyuki
    Sano, Kenji
    Higuchi, Yumiko
    Koya, Terutsugu
    Ochiai, Takanaga
    Koide, Masanori
    Uehara, Shunsuke
    Nakamura, Midori
    Sugiyama, Haruo
    Yonemitsu, Yoshikazu
    Okamoto, Masato
    Hongo, Kazuhiro
    JOURNAL OF NEUROSURGERY, 2015, 123 (04) : 989 - 997
  • [23] A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals
    Gowans, Eric J.
    Roberts, Stuart
    Jones, Kathryn
    Dinatale, Irene
    Latour, Philippe A.
    Chua, Brendan
    Eriksson, Emily M. Y.
    Chin, Ruth
    Li, Shuo
    Wall, Dominic M.
    Sparrow, Rosemary L.
    Moloney, Jude
    Loudovaris, Maureen
    Ffrench, Rosemary
    Prince, H. Miles
    Hart, Derek
    Zeng, Weng
    Torresi, Joseph
    Brown, Lorena E.
    Jackson, David C.
    JOURNAL OF HEPATOLOGY, 2010, 53 (04) : 599 - 607
  • [24] A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)
    Midgley, RS
    Kerr, DJ
    Mirza, N
    Palmer, D
    Adams, D
    Young, L
    BRITISH JOURNAL OF CANCER, 2002, 86 : S26 - S26
  • [25] Results of a Phase II trial of tumor lysate-pulsed dendritic cell vaccination for malignant glioma
    Yu, JS
    Black, KL
    Liu, GT
    Wheeler, CJ
    Wagenberg, M
    Das, A
    Mindlin, E
    Chu, RM
    Luptrawan, A
    Badruddoja, MA
    NEUROSURGERY, 2005, 57 (02) : 409 - 410
  • [26] A PHASE I TRIAL OF DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Reardon, David
    Desjardins, Annick
    Vredenburgh, James
    Friedman, Allan
    Sampson, John
    Gururangan, Sridharan
    Rich, Jeremy
    Friedman, Henry
    NEURO-ONCOLOGY, 2008, 10 (05) : 840 - 840
  • [27] Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis
    Artene, Stefan-Alexandru
    Turcu-Stiolica, Adina
    Hartley, Richard
    Ciurea, Marius Eugen
    Daianu, Oana
    Brindusa, Corina
    Alexandru, Oana
    Tataranu, Ligia Gabriela
    Purcaru, Stefana Oana
    Dricu, Anica
    ONCOTARGETS AND THERAPY, 2016, 9 : 6669 - 6676
  • [28] Dendritic Cell Immunotherapy for Malignant Gliomas
    Luptrawan, Anne
    Liu, Gentao
    Yu, John S.
    REVIEWS ON RECENT CLINICAL TRIALS, 2008, 3 (01) : 10 - 21
  • [29] Phase I/II clinical trial of immunotherapy by intratumoral administration of dendritic cells for patients with melanoma
    Saito, Masataka
    Fujita, Tomonobu
    Tanikawa, Akiko
    Ishida, Akaru
    Sakurai, Toshiharu
    Handa, Makoto
    Amagai, Masayuki
    Kawakami, Yutaka
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 328 - 328
  • [30] A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
    Rudnick, Jeremy D.
    Sarmiento, J. Manuel
    Uy, Benjamin
    Nuno, Miriam
    Wheeler, Christopher J.
    Mazer, Mia J.
    Wang, Hongqiang
    Hu, Jethro L.
    Chu, Ray M.
    Phuphanich, Surasak
    Black, Keith L.
    Yu, John S.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 74 : 187 - 193
12345